Related Experiment Video
Updated: Sep 21, 2025
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.7K
Biomarkers Accurately Inform Treatment Decisions in Localized Prostate Cancer
1Division of Urologic Surgery, Duke Cancer Institute, Durham, NC, USA.
European Urology Focus
|June 1, 2022
Abstract:
Biomarkers are now ubiquitous in prostate cancer care. In addition to longstanding use of prostate-specific antigen, we now have secondary serum-, urine-, and tissue-based markers that help in optimizing patient care and patient compliance with therapeutic recommendations. The ship has sailed: these markers are useful and are here to stay.
